Zepp Health Financials

ZEPP Stock  USD 2.80  0.01  0.36%   
Zepp Health Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. At this time, Zepp Health's Cash And Short Term Investments are relatively stable compared to the past year. As of 01/31/2025, Net Receivables is likely to grow to about 842.3 M, while Other Current Liabilities is likely to drop slightly above 711.8 M. Key indicators impacting Zepp Health's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.06730.0708
Notably Down
Slightly volatile
Current Ratio1.421.84
Significantly Down
Pretty Stable
Investors should never underestimate Zepp Health's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Zepp Health's cash flow, debt, and profitability to make informed and accurate decisions about investing in Zepp Health Corp.

Net Income

(181.36 Million)

  
Understanding current and past Zepp Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zepp Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Zepp Health's assets may result in an increase in income on the income statement.

Zepp Health Stock Summary

Zepp Health competes with VOXX International, LG Display, Emerson Radio, Universal Electronics, and Sonos. Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the Peoples Republic of China. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the Peoples Republic of China. Zepp Health operates under Consumer Electronics classification in the United States and is traded on New York Stock Exchange. It employs 1227 people.
Specialization
Information Technology, Technology Hardware & Equipment
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS98945L2043
CUSIP44331K103 98945L105 98945L204
LocationChina
Business AddressBuilding B2, Hefei,
SectorElectronic Equipment, Instruments & Components
IndustryInformation Technology
BenchmarkDow Jones Industrial
Websitewww.huami.com
Phone86 01 0594 03251
CurrencyUSD - US Dollar

Zepp Health Key Financial Ratios

Zepp Health Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets5.9B6.1B5.3B636.5M732.0M695.4M
Other Current Liab1.9B1.4B638.2M972.7M1.1B711.8M
Other Liab61.2M119.0M207.5M202.0M232.3M243.9M
Net Tangible Assets1.7B2.4B2.5B2.7B3.1B3.3B
Net Debt(1.6B)(208.7M)797.7M62.2M71.5M75.1M
Retained Earnings1.1B1.3B942.8M730.7M840.3M675.6M
Accounts Payable298.7M206.7M464.3M44.5M40.0M38.0M
Cash2.3B1.5B886.6M133.9M154.0M146.3M
Other Assets111.5M148.4M19.6M(1.9B)(1.7B)(1.7B)
Long Term Debt60M726.9M684.2M852.1M980.0M1.0B
Net Receivables1.2B825.8M802.4M466.5M536.5M842.3M
Good Will62.5M61.1M66.1M9.6M11.0M10.5M
Inventory1.2B1.2B1.0B602.7M693.1M733.6M
Other Current Assets157.8M363.0M213.3M169.6M195.1M133.3M
Total Liab3.2B3.2B2.6B283.2M325.7M309.4M
Short Long Term Debt504.7M461.8M968.4M487.6M560.8M307.0M
Total Current Assets4.8B3.9B3.0B2.2B2.6B2.9B
Short Term Debt512.0M511.9M554.3M72.7M83.6M79.4M
Intangible Assets145.2M135.6M123.3M9.9M11.4M10.8M
Common Stock157K159K162K23.1K26.6K25.3K

Zepp Health Key Income Statement Accounts

The reason investors look at the income statement is to determine what Zepp Health's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Tax Provision31.2M10.7M(65.9M)(15.8M)(14.2M)(13.5M)
Interest Income46.1M16.7M12.3M21.9M25.2M19.4M
Interest Expense22.6M44.9M57.0M6.7M7.7M7.4M
Total Revenue6.4B6.3B4.1B2.5B2.9B4.1B
Gross Profit1.3B1.3B803.1M657.8M756.4M903.0M
Operating Income78.2M93.9M(410.2M)(207.1M)(186.4M)(177.1M)
Ebit78.2M42.1M(412.7M)(142.1M)(127.9M)(121.5M)
Research Development538.0M515.1M517.1M361.8M416.1M363.5M
Ebitda105.3M93.9M(354.1M)(134.4M)(121.0M)(114.9M)
Cost Of Revenue5.1B4.9B3.3B1.8B2.1B3.2B
Income Before Tax265.6M106.7M(372.5M)(33.4M)(30.1M)(28.6M)
Net Income228.8M95.9M(306.7M)(212.1M)(190.9M)(181.4M)
Income Tax Expense31.2M10.7M(65.9M)(2.2M)(2.0M)(1.9M)
Minority Interest(953K)851K693K465K418.5K439.4K
Net Interest Income46.1M(28.2M)(44.7M)(25.8M)(23.2M)(22.0M)

Zepp Health Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(410.7M)(83.1M)187.9M51.9M59.6M62.6M
Investments(87.2M)(1.1B)(42.3M)54.7M49.2M51.7M
Change In Cash471.8M(766.2M)(536.2M)3.4M3.0M2.9M
Net Borrowings(13.2M)(20M)564.7M520.2M598.2M628.1M
Free Cash Flow72.5M(285.5M)(797.6M)40.5M36.4M23.4M
Depreciation27.1M51.9M58.6M7.7M8.8M8.4M
Other Non Cash Items55.7M39.2M22.7M(72.7M)(65.5M)(62.2M)
Capital Expenditures84.8M53.1M9.9M11.3M13.0M12.3M
Net Income229.7M137.0M(289.0M)(212.1M)(190.9M)(181.4M)
End Period Cash Flow2.3B1.5B973.3M140.7M161.8M153.7M
Change To Netincome101.6M85.3M111.4M102.7M118.2M76.0M

Zepp Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zepp Health's current stock value. Our valuation model uses many indicators to compare Zepp Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zepp Health competition to find correlations between indicators driving Zepp Health's intrinsic value. More Info.
Zepp Health Corp is rated second in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, Zepp Health's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Zepp Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Zepp Health Corp Systematic Risk

Zepp Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zepp Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Zepp Health Corp correlated with the market. If Beta is less than 0 Zepp Health generally moves in the opposite direction as compared to the market. If Zepp Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zepp Health Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zepp Health is generally in the same direction as the market. If Beta > 1 Zepp Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Zepp Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zepp Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Zepp Health growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.36

At this time, Zepp Health's Price Earnings To Growth Ratio is relatively stable compared to the past year.

Zepp Health January 31, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Zepp Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zepp Health Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zepp Health Corp based on widely used predictive technical indicators. In general, we focus on analyzing Zepp Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zepp Health's daily price indicators and compare them against related drivers.

Additional Tools for Zepp Stock Analysis

When running Zepp Health's price analysis, check to measure Zepp Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zepp Health is operating at the current time. Most of Zepp Health's value examination focuses on studying past and present price action to predict the probability of Zepp Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zepp Health's price. Additionally, you may evaluate how the addition of Zepp Health to your portfolios can decrease your overall portfolio volatility.